Akili Interactive Labs, Inc.: Clinical Trials

17 trials sponsored by Akili Interactive Labs, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 2 active not recruiting, 2 unknown. 14 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable14Completed 12, Active not recruiting 1, Unknown 1
Phase 21Completed 1

Follow Akili Interactive Labs, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EndeavorOTC® Research Study in College Students
EndeavorOTC® - Attention, Cognition
Not applicableUnknownAkili Interactive Labs, Inc.692024-01-102024-06-27
EndeavorOTC™ Prospective Product Registry
EndeavorOTC - ADHD
Active not recruitingAkili Interactive Labs, Inc.1982023-10-032024-06-27
EndeavorRx® Prospective Product Registry ("Expedition EndeavorRx")
EndeavorRx - ADHD
UnknownAkili Interactive Labs, Inc.1502022-06-012024-06-27
Software Treatment for Actively Reducing Severity of ADHD in Adults (STARS ADHD Adult)
Digital Treatment - Attention Deficit Hyperactivity Disorder
Not applicableCompletedAkili Interactive Labs, Inc.2232021-11-292023-02-28
Improving Cognitive Health in COVID-19 Survivors
AKL-T01 - Cognitive Dysfunction, Covid19
Phase 2CompletedWeill Medical College of Cornell University1102021-07-132024-02-29
Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents)
AKL-T01 - Attention Deficit Hyperactivity Disorder
Not applicableCompletedAkili Interactive Labs, Inc.1652021-06-292023-08-14
Study of Attention and Memory Treatments for Cancer Survivors
Endeavor: Computer-Based Cognitive Stimulation Intervention, Words!: Computer-Based Cognitive Stimulation Intervention, Quality of Life (QOL) Questionnaires - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Not applicableCompletedUniversity of California, San Francisco492021-03-012022-04-08
Electroencephalogram (EEG) Study of Inattention Following Treatment With AKL-T01
AKL-T01 - Attention Deficit Hyperactivity Disorder
Not applicableCompletedAkili Interactive Labs, Inc.282019-05-102023-11-14
Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant
AKL-T01 - Attention Deficit Hyperactivity Disorder
Not applicableCompletedAkili Interactive Labs, Inc.2062018-12-282023-08-09
Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus
Project EVO Multi- Treatment - Lupus Erythematosus, Systemic
Not applicableActive not recruitingNational Jewish Health602018-06-062020-01-13
Digital Cognition in Multiple Sclerosis
Tablet-based Game - Multiple Sclerosis, Cognitive Decline
Not applicableCompletedUniversity of California, San Francisco442018-04-012020-10-26
Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)
HOLD: Videogame - Major Depressive Disorder
Not applicableCompletedAkili Interactive Labs, Inc.842017-12-042018-11-21
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
EVO - Attention Deficit Disorder With Hyperactivity
Not applicableCompletedAkili Interactive Labs, Inc.1752016-08-012019-02-12
Sensitivity of Project: EVO Monitor Cognitive Measurements to Pharmacological Agents
Methylphenidate, Triazolam, Project: EVO - Healthy
Not applicableCompletedAkili Interactive Labs, Inc.182016-07-012016-11-07
Feasibility & Characterization of Project: EVO Monitor Cognitive Measurements
Project: EVO Monitor - Healthy
Not applicableCompletedAkili Interactive Labs, Inc.712016-06-012016-11-07
Software Treatment for Actively Reducing Severity of ADHD
AKL-T01, AKL-T09 - Attention Deficit Disorder With Hyperactivity
Not applicableCompletedAkili Interactive Labs, Inc.3482016-05-012020-08-14
Cognitive ADHD Videogame Exploratory Study
Neuro-typical controls and ADHD will receive EVO game play. - Attention Deficit Hyperactivity Disorder
Not applicableCompletedAkili Interactive Labs, Inc.842013-09-012017-12-13

Conditions studied

Attention Deficit Disorder with Hyperactivity (9)  ·  Cognitive Dysfunction (2)  ·  COVID-19 (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Hematologic Neoplasms (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Multiple Sclerosis (1)

Interventions

Methylphenidate (1)  ·  Quality of Life (1)  ·  Sugars (1)  ·  Surveys and Questionnaires (1)  ·  Triazolam (1)

Countries

United States (17)

Top investigators

Scott H Kollins, PhD (2)  ·  Scott Kollins, PhD (2)  ·  Ted Riley (2)  ·  Andrew J Cutler, MD (1)  ·  Caitlin Stamatis, PhD (1)  ·  Christine Miaskowski, RN, PhD (1)  ·  Daniel Lazkowitz, MD, PhD (1)  ·  Elysa J Marco, MD (1)  ·  Faith Gunning, PhD (1)  ·  Richard Keefe, PhD (1)  ·  Riley Bove, MD (1)

Results publications

PMID 38685016, PMID 39128918, PMID 29324745, PMID 32584155, PMID 33334505, PMID 33470940, PMID 34967751, PMID 34972140